Hepatic Glucocorticoid Receptor Action and Glucose Homeostasis
Endocrine Reviews · 2026
DOI: 10.1210/endrev/bnaf030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrine Reviews, 2026. Verfasst von Maggie Chang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Graduate Group and Department of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA 94720, USA. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Homeostasis, Liver, Glucose. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
One of the major metabolic functions of glucocorticoids (GC) is to maintain circulating glucose levels during stress, as glucose is the preferred energy source for the brain. Because of their potent anti-inflammatory and immune modulatory activities, GC are frequently used to treat inflammatory and autoimmune diseases. Chronic GC exposure, which can be a result of long-term GC pharmacotherapy and prolonged stress, however, causes undesired adverse effects that include hyperglycemia and insulin resistance. These adverse effects limit the application of GC therapy. GC act through an intracellular GC receptor (GR), a transcriptional regulator, to modulate the transcriptional rate of specific genes to exert physiological responses. The liver is a major target tissue of GC to modulate glucose homeostasis. In this review, we discuss the mechanisms of GR-activated transcription of genes involved in glucose metabolism and how hepatic GR primary target genes participate in the regulation of insulin sensitivity and glucose homeostasis. Transcriptional coregulators involved in GR-regulated transcription of glucose metabolism genes and signaling pathways specifically activated upon chronic GC exposure to induce glucose disorders are introduced. Metabolic profiles of liver-specific GR knockout mice are also reviewed. Finally, individual-specific GC responses and mechanisms underlying these phenomena are discussed. Overall, more extensive studies of the mechanisms of GR-regulated hepatic glucose homeostasis not only will expand our knowledge of the regulation of metabolic homeostasis but are also critical for developing improved GC pharmacotherapy and novel approaches to tackle metabolic disorders by targeting GR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Graduate Group and Department of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA 94720, USA.
ORCID-Profile: Maggie Chang, Jen-Chywan Wang
Förderung
- NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- UCSF Liver Center
Zitieren
APA
Chang, M., & Wang, J. C. (2026). Hepatic Glucocorticoid Receptor Action and Glucose Homeostasis. Endocrine Reviews. https://doi.org/10.1210/endrev/bnaf030
Vancouver
Chang M, Wang JC. Hepatic Glucocorticoid Receptor Action and Glucose Homeostasis. Endocrine Reviews. 2026. doi:10.1210/endrev/bnaf030
BibTeX
@article{Chang2026,
author = {Chang, Maggie and Wang, Jen-Chywan},
title = {Hepatic Glucocorticoid Receptor Action and Glucose Homeostasis},
journal = {Endocrine Reviews},
year = {2026},
doi = {10.1210/endrev/bnaf030}
}
EUVIMED